Chronic Myeloid Leukemia

>

Latest News

TERN-701 Gains FDA Orphan Drug Designation in Chronic Myeloid Leukemia
TERN-701 Gains FDA Orphan Drug Designation in Chronic Myeloid Leukemia

March 12th 2024

The BCR-ABL tyrosine kinase inhibitor TERN-701 has been granted an orphan drug designation from the FDA for the treatment of chronic myeloid leukemia.

FDA Accepts Resubmitted NDA for Dasynoc in CML and ALL
FDA Accepts Resubmitted NDA for Dasynoc in CML and ALL

February 12th 2024

Asciminib Delivers Superior Responses in Phase 3 Ph+ CML Trial
Asciminib Delivers Superior Responses in Phase 3 Ph+ CML Trial

January 8th 2024

Asciminib Demonstrates Greater Efficacy and Safety Vs Bosutinib in CML
Asciminib Demonstrates Greater Efficacy and Safety Vs Bosutinib in CML

December 12th 2023

Use of Orca-T Shows Promise for Patients With Hematologic Malignancies
Use of Orca-T Shows Promise for Patients With Hematologic Malignancies

December 10th 2023

Video Series
Video Interviews

More News